[ad_1]
New York, June 23, 2021 (GLOBE NEWSWIRE) – Reportlinker.com announced the release of the report “Therapeutic Plasma Exchange Market Research Report by Technology, Indication, Product, End User, Region-Global Forecast to 2026- Cumulative impact of COVID-19”- https://www.reportlinker.com/p06088349/?utm_source=GNW
The global therapeutic plasma trading market in 2020 is estimated to be USD 422.8 million, and is expected to reach USD 460.6 million by 2021, with a compound annual growth rate (CAGR) of 9.28% from 2020 to 2026, and reaching USD 72203 million by 2026 .
Market Statistics:
The report provides market sizes and forecasts for the five major currencies (USD, Euro, British Pound, Japanese Yen and Australian Dollar). When currency exchange data is readily available, it can help organizational leaders make better decisions. This report uses 2018 and 2019 as the historical years, 2020 as the base year, 2021 as the estimated year, and 2022-2026 as the forecast period.
Market segmentation and coverage:
This research report categorizes therapeutic plasma exchanges to forecast revenue and analyze trends in each of the following submarkets:
Based on technology, the therapeutic plasma exchange market has been studied across centrifugation and membrane separation.
According to the indications, the therapeutic plasma exchange market was studied, involving blood diseases, metabolic diseases, neurological diseases and kidney diseases. Further study blood diseases in atypical hemolytic uremic syndrome, hyperviscosity syndrome, severe/symptomatic cryoglobulinemia, and thrombotic thrombocytopenic purpura. Nervous system diseases have been further studied in chronic inflammatory demyelinating polyneuropathy, Guillain-Barré syndrome, multiple sclerosis, myasthenia gravis, and PANDAS. Renal diseases were further studied in antibody-mediated renal transplant rejection, Goodpasture syndrome, and Wegener’s granulomatosis.
Based on Product, researched the therapeutic plasma exchange market across consumables and equipment.
Based on the end user, research has been conducted on the therapeutic plasma exchange market of blood collection centers and blood component suppliers, as well as hospitals and blood transfusion centers.
Based on geography, therapeutic plasma…
The full story on Benzinga.com
[ad_2]
Source link
